| Balance Sheet of Alembic Pharmaceuticals (in Rs. Cr.) |
Mar 25 |
Mar 24 |
Mar 23 |
Mar 22 |
Mar 21 |
|
| |
12 mths |
12 mths |
12 mths |
12 mths |
12 mths |
|
| EQUITIES AND LIABILITIES |
|
|
|
|
|
|
| SHAREHOLDER'S FUNDS |
|
|
|
|
|
|
| Equity Share Capital |
39.31 |
39.31 |
39.31 |
39.31 |
39.31 |
|
| Total Share Capital |
39.31 |
39.31 |
39.31 |
39.31 |
39.31 |
|
| Reserves and Surplus |
5,155.43 |
4,869.60 |
4,374.98 |
5,251.03 |
5,214.93 |
|
| Total Reserves and Surplus |
5,155.43 |
4,869.60 |
4,374.98 |
5,251.03 |
5,214.93 |
|
| Total Shareholders Funds |
5,194.74 |
4,908.91 |
4,414.29 |
5,290.34 |
5,254.24 |
|
| NON-CURRENT LIABILITIES |
|
|
|
|
|
|
| Long Term Borrowings |
0.00 |
0.00 |
0.00 |
0.00 |
199.89 |
|
| Deferred Tax Liabilities [Net] |
0.00 |
0.00 |
0.00 |
46.40 |
46.12 |
|
| Other Long Term Liabilities |
37.62 |
52.91 |
58.63 |
62.03 |
67.73 |
|
| Long Term Provisions |
124.31 |
109.51 |
106.20 |
95.82 |
84.73 |
|
| Total Non-Current Liabilities |
161.93 |
162.42 |
164.83 |
204.25 |
398.47 |
|
| CURRENT LIABILITIES |
|
|
|
|
|
|
| Short Term Borrowings |
1,142.22 |
420.04 |
635.07 |
629.99 |
0.02 |
|
| Trade Payables |
724.57 |
619.96 |
595.86 |
570.21 |
516.94 |
|
| Other Current Liabilities |
247.54 |
222.33 |
250.41 |
315.61 |
554.91 |
|
| Short Term Provisions |
85.27 |
64.88 |
69.96 |
63.64 |
51.60 |
|
| Total Current Liabilities |
2,199.60 |
1,327.21 |
1,551.30 |
1,579.45 |
1,123.47 |
|
| Total Capital And Liabilities |
7,556.27 |
6,398.54 |
6,130.42 |
7,074.04 |
6,776.18 |
|
| ASSETS |
|
|
|
|
|
|
| NON-CURRENT ASSETS |
|
|
|
|
|
|
| Tangible Assets |
2,513.47 |
2,535.66 |
2,377.45 |
1,714.72 |
1,452.83 |
|
| Intangible Assets |
0.00 |
0.00 |
0.00 |
56.38 |
0.00 |
|
| Capital Work-In-Progress |
837.23 |
524.36 |
601.28 |
2,205.79 |
1,927.63 |
|
| Other Assets |
0.00 |
0.00 |
0.00 |
0.00 |
8.35 |
|
| Fixed Assets |
3,350.70 |
3,060.02 |
2,978.73 |
4,075.33 |
3,388.81 |
|
| Non-Current Investments |
259.56 |
226.68 |
229.27 |
219.36 |
978.25 |
|
| Deferred Tax Assets [Net] |
77.42 |
78.83 |
78.16 |
0.00 |
0.00 |
|
| Long Term Loans And Advances |
71.24 |
11.16 |
10.29 |
0.00 |
0.00 |
|
| Other Non-Current Assets |
31.15 |
33.30 |
53.75 |
34.89 |
35.17 |
|
| Total Non-Current Assets |
3,790.07 |
3,409.99 |
3,350.20 |
4,329.58 |
4,402.23 |
|
| CURRENT ASSETS |
|
|
|
|
|
|
| Current Investments |
0.00 |
0.00 |
0.00 |
0.00 |
186.97 |
|
| Inventories |
1,976.34 |
1,353.07 |
1,275.13 |
1,396.83 |
1,316.78 |
|
| Trade Receivables |
1,480.67 |
1,340.12 |
1,201.20 |
988.33 |
407.90 |
|
| Cash And Cash Equivalents |
20.85 |
26.49 |
28.46 |
21.90 |
61.22 |
|
| Short Term Loans And Advances |
12.88 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| OtherCurrentAssets |
275.46 |
268.87 |
275.43 |
337.40 |
401.08 |
|
| Total Current Assets |
3,766.20 |
2,988.55 |
2,780.22 |
2,744.46 |
2,373.95 |
|
| Total Assets |
7,556.27 |
6,398.54 |
6,130.42 |
7,074.04 |
6,776.18 |
|
| OTHER ADDITIONAL INFORMATION |
|
|
|
|
|
|
| CONTINGENT LIABILITIES, COMMITMENTS |
|
|
|
|
|
|
| Contingent Liabilities |
240.49 |
193.55 |
326.18 |
228.15 |
327.06 |
|
| CIF VALUE OF IMPORTS |
|
|
|
|
|
|
| Raw Materials |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Stores, Spares And Loose Tools |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Trade/Other Goods |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Capital Goods |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| EXPENDITURE IN FOREIGN EXCHANGE |
|
|
|
|
|
|
| Expenditure In Foreign Currency |
1,229.26 |
804.89 |
684.56 |
672.76 |
684.49 |
|
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS |
|
|
|
|
|
|
| Dividend Remittance In Foreign Currency |
-- |
-- |
-- |
-- |
-- |
|
| EARNINGS IN FOREIGN EXCHANGE |
|
|
|
|
|
|
| FOB Value Of Goods |
-- |
-- |
-- |
-- |
-- |
|
| Other Earnings |
3,412.99 |
3,182.64 |
2,621.00 |
2,325.09 |
3,602.01 |
|
| BONUS DETAILS |
|
|
|
|
|
|
| Bonus Equity Share Capital |
-- |
-- |
-- |
-- |
-- |
|
| NON-CURRENT INVESTMENTS |
|
|
|
|
|
|
| Non-Current Investments Quoted Market Value |
-- |
-- |
-- |
-- |
-- |
|
| Non-Current Investments Unquoted Book Value |
259.56 |
226.68 |
229.27 |
219.36 |
978.25 |
|
| CURRENT INVESTMENTS |
|
|
|
|
|
|
| Current Investments Quoted Market Value |
-- |
-- |
-- |
-- |
-- |
|
| Current Investments Unquoted Book Value |
-- |
-- |
-- |
-- |
-- |
|
Source : Dion Global Solutions Limited
